Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (6): 1469-1475.doi: 10.13481/j.1671-587X.20210617
• Research in basic medicine • Previous Articles Next Articles
Peisen HU(),Hongquan CUI,Junfeng ZHAO,Zhizhou WU,Jiaotuo WANG
Received:
2021-03-06
Online:
2021-11-28
Published:
2021-12-14
Contact:
Peisen HU
E-mail:yu589jian@163.com
CLC Number:
Peisen HU,Hongquan CUI,Junfeng ZHAO,Zhizhou WU,Jiaotuo WANG. Regulatory effect of Danggui Liuhuang Decoction on immune function of prostate cancer-bearing mice and its mechanism[J].Journal of Jilin University(Medicine Edition), 2021, 47(6): 1469-1475.
Tab.1
Spleen coefficients and thymus coefficients of mice in various groups [n=10,x±s,wB/(mg·g-1)]"
Group | Spleen coefficient | Thymus coefficient |
---|---|---|
Control | 5.88±0.62 | 0.43±0.06 |
Model | 9.04±0.91* | 0.97±0.11* |
Danggui Liuhuang Decontion Low dose | 8.19±0.83△ | 0.85±0.10△ |
High dose | 7.42±0.77△# | 0.69±0.08△# |
Cisplatin | 6.63±0.69△#○ | 0.58±0.07△#○ |
F | 26.142 | 61.730 |
P | <0.001 | <0.001 |
Tab.2
Tumor volumes and inhibitory rates of tumor of mice in various groups"
Group | Tumor volume (V/mm3) | Inhibitory rate of tumor(η/%) |
---|---|---|
Model | 1 367.44±152.66 | - |
Danggui Liuhuang Decontion Low dose | 1 128.69±140.68*△ | 17.45±3.22 |
High dose | 873.42±92.54*△ | 36.12±3.46*# |
Cisplatin | 685.17±88.23*△# | 49.89±3.97*△# |
F | 59.656 | 208.727 |
P | <0.001 | <0.001 |
Tab.3
Percentages of CD4+ and CD8+T lymphocytes in peripheral blood of mice in various groups"
Group | Percentage of CD4+ T lymphocytes | Percentage of CD8+ T lymphocytes |
---|---|---|
Control | 33.35±4.34 | 12.16±1.46 |
Model | 16.12±2.25* | 26.89±2.97* |
Danggui Liuhuang Decontion Low dose | 20.48±2.31*△ | 22.76±2.65*△ |
High dose | 24.27±2.49*△# | 18.46±2.16*△# |
Cisplatin | 29.49±3.28*△#○ | 15.75±1.88*△#○ |
F | 51.244 | 63.907 |
P | <0.01 | <0.01 |
Tab.4
Expression levels of PD-1 and PD-L1 proteins in spleen tissue of mice in various groups"
Group | PD-1 | PD-L1 |
---|---|---|
Control | 0.43±0.05 | 0.45±0.06 |
Model | 1.24±0.13* | 1.26±0.14* |
Danggui Liuhuang Decontion Low dose | 1.03±0.11*△ | 1.07±0.13*△ |
High dose | 0.88±0.09*△# | 0.86±0.10*△# |
Cisplatin | 0.62±0.07*△#○ | 0.67±0.08*△#○ |
F | 116.348 | 90.327 |
P | <0.001 | <0.001 |
1 | JONASCH E. NCCN guidelines updates: management of metastatic kidney cancer[J]. J Natl Compr Cancer Netw: JNCCN, 2019, 17(5.5): 587-589. |
2 | CENTER M M, JEMAL A, LORTET-TIEULENT J, et al. International variation in prostate cancer incidence and mortality rates[J].Eur Urol,2012, 61(6):1079-1092. |
3 | GUILHEN M, HENNEQUIN C, OUZAID I, et al. Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia[J]. Radiat Oncol, 2018, 13(1): 209. |
4 | WOUTER S, ARJEN V D S,VAN D L V,et al. Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients[J]. PLoS One, 2018, 13(7): e0197757. |
5 | 谢金波,彭 波.良性前列腺增生的流行病学特征及危险因素研究进展[J].同济大学学报(医学版),2021,42(4):568-573. |
6 | CHEN C H, LI S X, XIANG L X, et al. HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224[J]. Biochem Biophys Res Commun, 2018, 503(1): 228-234. |
7 | KIM C G, KIM K H, PYO K H, et al. Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer[J]. Ann Oncol, 2019, 30(7): 1104-1113. |
8 | 龚艳琳, 高明松, 周 密, 等. 当归六黄汤对阴虚火旺型甲状腺功能亢进患者胎球蛋白A及胰岛素抵抗的影响[J]. 湖北中医药大学学报, 2019, 21(2): 67-69. |
9 | 郭 逸, 裴 迅, 房骢骢, 等. 当归六黄汤对桥本甲状腺炎临床疗效及免疫功能的影响[J]. 世界中医药, 2019, 14(9): 2290-2294. |
10 | 毛晶磊, 熊 鑫, 宫 浩. 姜黄素对前列腺癌荷瘤小鼠肿瘤生长及免疫功能的影响[J]. 中华男科学杂志, 2019, 25(7): 590-594. |
11 | 代 伟. 加味当归六黄汤联合甲巯咪唑片治疗阴虚火旺型甲状腺功能亢进症的疗效及安全性[J]. 现代中西医结合杂志, 2019, 28(3): 274-276, 283. |
12 | JI P, LI C, WEI Y, et al. Screening study of blood-supplementing active components in water decoction of Angelica sinensis processed with yellow rice wine based on response surface methodology[J]. Pharm Biol, 2020, 58(1): 1167-1176. |
13 | WANG M, CHEN Y, HU P, et al. Neoclerodane diterpenoids from Scutellaria barbata with cytotoxic activities[J]. Nat Prod Res, 2020, 34(10): 1345-1351. |
14 | ZHANG G Y, FANG H, LI Y K,et al. Neuroprotective effect of astragalus polysacharin on streptozotocin (STZ)-induced diabetic rats[J].Med Sci Monit,2019,25: 135-141. |
15 | SHI Y Y, LIU X J, FREDIMOSES M, et al. FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma[J]. J Cell Biochem,2018,119(2):2231-2239. |
16 | ZHENG Y M, SHEN J Z, WANG Y, et al. Anti-oxidant and anti-cancer activities of Angelica dahurica extract via induction of apoptosis in colon cancer cells[J]. Phytomedicine, 2016, 23(11): 1267-1274. |
17 | BAMODU O A, KUO K T, WANG C H, et al. Astragalus polysaccharides (PG2) enhances the M1 polarization of macrophages, functional maturation of dendritic cells, and T cell-mediated anticancer immune responses in patients with lung cancer [J]. Nutrients, 2019, 11(10):2264. |
18 | GUO Y L, ZHANG Z X, WANG Z X, et al. Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway[J]. Biosci Rep, 2020, 40(3): BSR20193396. |
19 | YANG S J, ZHANG Q Y, LIU S, et al. PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer[J]. Am J Clin Exp Urol, 2016, 4(1): 1-8. |
20 | PHILIPPOU Y, SJOBERG H T, MURPHY E, et al. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model[J]. Br J Cancer, 2020, 123(7): 1089-1100. |
[1] | Yang ZHANG,Huamao JIANG. Inhibitory effect of nobiletin on growth of human prostate cancer DU145 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1260-1266. |
[2] | YUE Yuan, XU Yinglian, WANG Jingjing, SUN Minying, ZHANG Zenan, ZHAO Xinyue, LI Zongpu, TAI Guixiang. Inhibitory effects of down-regulation of JNK enzymatic activity on growth of human prostate cancer cells, hepatocellular carcinoma cells and breast cancer cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1046-1051. |
[3] | LI Wei, YU Jiahui, WANG Xinting, WANG Chunmei, LI He, CHEN Jianguang, SUN Jinghui. Immunomodulatory effect of Schisandra chinensis lignans in cyclophosphamide-induced immunodeficiency mice [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 294-299. |
[4] | FANG Fang, FANG Qing, ZHAO Liang-zhong, LI Qiang, CHEN Shuang, ZHANG Duo, WANG Liguo. Iihibition of autophagy of prostate cancer PC-3 cells by CD147 with Beclin-1 [J]. Journal of Jilin University Medicine Edition, 2016, 42(01): 15-18. |
[5] | FANG Fang, ZHANG Wansheng, TANG Huayong, ZHAO Liangzhong, CHEN Shuang, LI Qiang, WANG Liguo. Influence of CD147 RNA interference in invasion of prostate cancer LNCaP-AI cells in vitro [J]. Journal of Jilin University Medicine Edition, 2015, 41(03): 460-463. |
[6] | HUA Xing,PAN Wen-hai. Construction of lentiviral vector of DAB2IP gene and its expression in prostate carcinoma PC3 cells [J]. Journal of Jilin University Medicine Edition, 2014, 40(05): 938-942. |
[7] | ZHANG Da-tian,SHI Jian-guo,ZHANG Qiang,LIU Yan . Influence of sirtinol in cell cycle of prostate cancer DU145 cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(05): 967-971. |
[8] | LU Feng-ying,LIAO Xin-hong,LI Zhi-xian,GAO Yong,LI Tian-yu. Application of microvascular density in determination of transrectal ultrasound hemodgynamics in differential diagnosis of prostate cancer and chronic prostatitis [J]. Journal of Jilin University Medicine Edition, 2014, 40(05): 1104-1108. |
[9] | KONG Fan-li,SUN Xin,TONG Hai-bin,LIN Qi,LIU Yan,LI Yu-lin. Inhibitory effect of water-soluble polysaccharide alkali-extracted from Pleurotus ostreatus and its mechanism [J]. J4, 2012, 38(6): 1091-1095. |
[10] | CHENG Hong,ZHAO Li-jing,LU Yu-ming,XU Duo,SHAO Chen,ZHAO Li-juan,DONG Yan. Inductive effect of 20 (s)-proto-panaxdiol on apoptosis of human prostate cancer |PC3 cells cultivated  |in vitro and its mechanism [J]. J4, 2012, 38(3): 482-485. |
[11] | LIANG Zuo-Wen, ZHAO Li-Jing, JIA Hui-Jie, LI Xin, GAO Li-Fang, ZHANG Ling, ZHAO Xue-Jian. Construction of siRNA-Stat3 and GRIM-19 co-expression plasmid and study on its function [J]. J4, 2010, 36(5): 858-861. |
[12] | GUO Ya-Xiong, LIU Yan-Bo, LI De-Long, HAN Xiang-Bei, XU Duo, CHENG Hong, ZHAO Li-Jing, ZHAO Li-Juan, DONG Yan. Growth inhibition of 20(s)-protopanaxadiol on prostate cancer cells RM-1 in mice and its mechanism [J]. J4, 2010, 36(2): 349-353. |
[13] | LI Ran-wei,WANG Ke,YANG Ze-cheng,LIU Yong-hong,LU Jia-yin,WU Dan-hua,ZHAO Yan-ying. Inhibition of siRNA on VEGF expression in PC-3 cell line and cell proliferation [J]. J4, 2008, 34(4): 585-589. |
[14] | CHEN Li-ping, WU Shan-li, FEHR Erzsébet, ALTDORFER Károly,CHI Bao-rong. Changes of immunoreactive nerve fibres in rats with iodoacetamide-induced gastritis [J]. J4, 2007, 33(1): 75-77. |
[15] | PAN Yu-zhuo, LI Yang, ZHAO Yan-ying, ZHAO Dan, YU Bin, ZHAO Xue-jian. Inhibitory effect of DIM on growth of human prostate cancer cell PC3M [J]. J4, 2006, 32(6): 1034-1036. |